Kazutoshi Horie

617 total citations
17 papers, 508 citations indexed

About

Kazutoshi Horie is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Kazutoshi Horie has authored 17 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Kazutoshi Horie's work include Drug Transport and Resistance Mechanisms (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Kazutoshi Horie is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Kazutoshi Horie collaborates with scholars based in Japan and United States. Kazutoshi Horie's co-authors include Ronald T. Borchardt, Fuxing Tang, Kazuyoshi Masuda, Ikuo Yamashina, Toshiro Yano, Ikuo Funakoshi, Masahiro Sakagami, Hiroshi Hamana, Koichiro Hirano and Shingo Sakamoto and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Archives of Biochemistry and Biophysics.

In The Last Decade

Kazutoshi Horie

17 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazutoshi Horie Japan 12 299 183 164 89 50 17 508
Jolanta Tanianis-Hughes United Kingdom 7 219 0.7× 312 1.7× 95 0.6× 64 0.7× 30 0.6× 8 611
Sarah Goldenberg United States 11 447 1.5× 285 1.6× 156 1.0× 57 0.6× 42 0.8× 13 598
Dominic Surry United Kingdom 16 354 1.2× 146 0.8× 169 1.0× 269 3.0× 47 0.9× 19 639
Heleen A. Bardelmeijer Netherlands 11 414 1.4× 166 0.9× 157 1.0× 152 1.7× 45 0.9× 12 667
Jacques Ferté France 5 268 0.9× 211 1.2× 68 0.4× 38 0.4× 51 1.0× 7 477
Er-jia Wang China 8 255 0.9× 159 0.9× 107 0.7× 116 1.3× 40 0.8× 9 468
Paresh P. Chothe United States 14 299 1.0× 178 1.0× 139 0.8× 129 1.4× 28 0.6× 34 571
Tohru SAEKI Japan 15 521 1.7× 248 1.4× 210 1.3× 91 1.0× 37 0.7× 31 763
Kazumi Sano Japan 12 386 1.3× 301 1.6× 94 0.6× 52 0.6× 27 0.5× 29 585
Daniel C. Kemp United States 9 124 0.4× 179 1.0× 56 0.3× 133 1.5× 48 1.0× 11 488

Countries citing papers authored by Kazutoshi Horie

Since Specialization
Citations

This map shows the geographic impact of Kazutoshi Horie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazutoshi Horie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazutoshi Horie more than expected).

Fields of papers citing papers by Kazutoshi Horie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazutoshi Horie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazutoshi Horie. The network helps show where Kazutoshi Horie may publish in the future.

Co-authorship network of co-authors of Kazutoshi Horie

This figure shows the co-authorship network connecting the top 25 collaborators of Kazutoshi Horie. A scholar is included among the top collaborators of Kazutoshi Horie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazutoshi Horie. Kazutoshi Horie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Okamura, Noboru, Shingo Sakamoto, Hiroshi Hasegawa, et al.. (2008). Role of Na+/L-carnitine Transporter (OCTN2) in Renal Handling of Pivaloylcarnitine and Valproylcarnitine Formed during Pivalic Acid-containing Prodrugs and Valproic Acid Treatment. Drug Metabolism and Pharmacokinetics. 23(4). 293–303. 21 indexed citations
3.
Sakamoto, Shingo, Hiroyuki Kusuhara, Kenji Miyata, et al.. (2007). Glucuronidation Converting Methyl 1-(3,4-Dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a Potent Apical Sodium-Dependent Bile Acid Transporter Inhibitor, Resulting in a Hypocholesterolemic Action. Journal of Pharmacology and Experimental Therapeutics. 322(2). 610–618. 19 indexed citations
4.
Horie, Kazutoshi, Masahiro Sakagami, Kazuyoshi Masuda, et al.. (2004). Sialyl Lewis X-Carboxymethylpullulan Conjugate: A Novel Homing Device to Spleen and Lymph Nodes. Biological and Pharmaceutical Bulletin. 27(8). 1275–1280. 3 indexed citations
5.
Horie, Kazutoshi, Fuxing Tang, & Ronald T. Borchardt. (2003). Isolation and Characterization of Caco-2 Subclones Expressing High Levels of Multidrug Resistance Protein Efflux Transporter. Pharmaceutical Research. 20(2). 161–168. 34 indexed citations
6.
Masuda, Kazuyoshi, Kazutoshi Horie, Ryuji Suzuki, Takayoshi Yoshikawa, & Koichiro Hirano. (2003). Oral-Antigen Delivery via a Water-in-Oil Emulsion System Modulates the Balance of the Th1/Th2 Type Response in Oral Tolerance. Pharmaceutical Research. 20(1). 130–134. 6 indexed citations
7.
Tang, Fuxing, Kazutoshi Horie, & Ronald T. Borchardt. (2002). Are MDCK Cells Transfected with the Human MRP2 Gene a Good Model of the Human Intestinal Mucosa?. Pharmaceutical Research. 19(6). 773–779. 75 indexed citations
8.
Masuda, Kazuyoshi, Kazutoshi Horie, Ryuji Suzuki, Takayoshi Yoshikawa, & Koichiro Hirano. (2002). Oral Delivery of Antigens in Liposomes with Some Lipid Compositions Modulates Oral Tolerance to the Antigens. Microbiology and Immunology. 46(1). 55–58. 14 indexed citations
9.
Tang, Fuxing, Kazutoshi Horie, & Ronald T. Borchardt. (2002). Are MDCK Cells Transfected with the Human MDR1 Gene a Good Model of the Human Intestinal Mucosa?. Pharmaceutical Research. 19(6). 765–772. 179 indexed citations
10.
Masuda, Kazuyoshi, et al.. (2001). Evaluation of Carboxymethylpullulan as a Novel Carrier for Targeting Immune Tissues. Pharmaceutical Research. 18(2). 217–223. 16 indexed citations
11.
Horie, Kazutoshi, et al.. (2000). Effect of the Sialyl Lewis X (SLe) Moiety on Splenic Accumulation of SLex‐Carboxymethylpullulan Conjugate. Microbiology and Immunology. 44(5). 401–404. 4 indexed citations
12.
Horie, Kazutoshi, et al.. (1999). Enhanced accumulation of sialyl Lewis X-carboxymethylpullulan conjugate in acute inflammatory lesion.. Pharmaceutical Research. 16(2). 314–320. 15 indexed citations
13.
Sakagami, Masahiro, Kazutoshi Horie, Kazutaka Nakamoto, Takayuki Kawaguchi, & Hiroshi Hamana. (1998). Sialyl Lewis X-polysaccharide conjugates: Targeting inflammatory lesions. Bioorganic & Medicinal Chemistry Letters. 8(19). 2783–2786. 10 indexed citations
14.
Muranushi, Noriyuki, Kazutoshi Horie, Kazuyoshi Masuda, & Koichiro Hirano. (1994). Characteristics of Ceftibuten Uptake into Caco-2 Cells. Pharmaceutical Research. 11(12). 1761–1765. 19 indexed citations
15.
Funakoshi, Ikuo, Hiroshi Kato, Kazutoshi Horie, et al.. (1992). Molecular cloning of cDNAs for human fibroblast nucleotide pyrophosphatase. Archives of Biochemistry and Biophysics. 295(1). 180–187. 56 indexed citations
16.
Horie, Kazutoshi, Toshiro Yano, Ikuo Funakoshi, & Ikuo Yamashina. (1988). Elevated nucleotide pyrophosphatase activity in cultured skin fibroblasts from patients with Lowe's syndrome. Clinica Chimica Acta. 177(1). 41–48. 9 indexed citations
17.
Yano, Toshiro, et al.. (1987). Immunoaffinity purification and characterization of nucleotide pyrophosphatase from human placenta. Biochemical and Biophysical Research Communications. 147(3). 1061–1069. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026